Evolution of COVID Management - A COVID Update

This activity is designed for health care providers, to examine the latest advances in the management of COVID-19. This activity will discuss COVID in the US, vaccination, long term consequences, optimizing diagnosis, cases across the spectrum, and COVID in special populations. 

Target Audience

Healthcare providers in all specialties who are being impacted by COVID-19, including physicians, research scientists, physician assistants, nurse practitioners, nurses, and caregivers with a particular interest in prevention, treatment and patient care.

Learning Objectives

  • Describe the current global epidemiology of SARS CoV-2 variants
  • List the SARS CoV-2 variants that may be of concern in the near future
  • Discuss current research initiatives related to the COVID-19 pandemic
  • Identify promising, innovative solutions in treatment strategies for patients with COVID-19
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
    HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    HCA Healthcare Continental Division designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Course opens: 
01/09/2023
Course expires: 
12/31/2024
Cost:
$0.00
Rating: 
0

Jaya Kumar, MD

Luciano Lemos-Filho, MD, MS

Disclosure: There are no relevant financial relationships to report for those individuals in a position to control the content of this CME Activity 

Accreditation: The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation: The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose. 

Available Credit

  • 1.00 AMA PRA Category 1 Credit
    HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    HCA Healthcare Continental Division designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or register to take this course.

Instructions needed